Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Provepharm Life Solutions

    Client Virtual Booth

    PROVEPHARM LIFE SOLUTIONS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Provepharm Life Solutions
    France Flag
    Country
    Country
    France
    Address
    Address
    22 rue Marc Donadille F-13013 Marseille
    Telephone
    Telephone
    +33 (0)491 086 930
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.provepharm.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/provepharmlifesolutions/
    Twitter
    Twitter
    https://twitter.com/provepharm?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    left grey arrow
    right gray arrow
    Full View ScreenFull Screen View
    Calyptus Pharma Announces Partnership with Provepharm
    Calyptus Pharma Announces Partnership with Provepharm

    https://www.prnewswire.com/news-releases/calyptus-pharmaceuticals-announces-partnership-with-provepharm-to-accelerate-development-of-an-acute-care-injectable-product-301608663.html

    PRNEWSWIRE
    22 Aug 2022
    Share Share
    Provepharm receives US FDA approval to produce APIs for US market
    Provepharm receives US FDA approval to produce APIs for US market

    http://www.pharmabiz.com/NewsDetails.aspx?aid=144321&sid=2

    PHARMABIZ
    30 Nov 2021
    Share Share
    Axyntis Group signs 3 agreements offering opportunities to develop new activities and technologies through 3 million euros of investment
    Axyntis Group signs 3 agreements offering opportunities to develop new activities and technologies through 3 million euros of investment

    https://www.pharmacompass.com/pdf/news/axyntis-group-signs-3-agreements-offering-opportunities-to-develop-new-activities-and-technologies-through-3-million-euros-of-investment-1624093761.pdf

    PRESS RELEASE
    25 Oct 2017
    Share Share
    Provepharm's Provayblue(Methylene Blue) approved in US for methemoglobinemia
    Provepharm's Provayblue(Methylene Blue) approved in US for methemoglobinemia

    https://www.pharmacompass.com/pdf/news/provepharms-provaybluemethylene-blue-approved-in-us-for-methemoglobinemia-1460462166.pdf

    FDA
    08 Apr 2016
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    polpharma-m-2024-04-15

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search